News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
Bayer HealthCare Wins European Approval for Xarelto Pill
October 1, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FRANKFURT, Oct 1 (Reuters) - Bayer's blood thinning pill Xarelto has been approved by the European Commission for the prevention of blood clots after hip or knee replacement surgery, the German drugmaker said on Wednesday.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
MORE ON THIS TOPIC
Mergers & acquisitions
Lilly-Verve Proxy Filing Reveals Tumult After Departure of FDA’s Marks
June 26, 2025
·
4 min read
·
Annalee Armstrong
Policy
Former CBER Chief Marks Decries New FDA COVID-19 Framework
June 26, 2025
·
3 min read
·
Tristan Manalac
Duchenne muscular dystrophy
FDA Reviews Sarepta’s Elevidys After Second Patient Death
June 25, 2025
·
2 min read
·
Tristan Manalac
FDA
FDA Names Psychedelic Proponent as CDER Deputy Director, Top Spot Remains Open
June 25, 2025
·
2 min read
·
Tristan Manalac
